Cargando…
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH)
INTRODUCTION: The EAGLE-DH study assessed the efficacy and safety of esaxerenone in hypertensive patients with diabetes mellitus receiving sodium-glucose cotransporter 2 (SGLT2) inhibitors. METHODS: In this multicenter, open-label, prospective, interventional study, esaxerenone was started at 1.25 o...
Autores principales: | Motoki, Hirohiko, Inobe, Yoshito, Fukui, Toshiki, Iwasaki, Arata, Hiramitsu, Shinya, Koyama, Sekiya, Masuda, Izuru, Sekimura, Noriyuki, Yamamoto, Kazuya, Sato, Ai, Komatsu, Mitsuhisa, Taguchi, Takashi, Shiosakai, Kazuhito, Sugimoto, Kotaro, Kuwahara, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567833/ https://www.ncbi.nlm.nih.gov/pubmed/37733211 http://dx.doi.org/10.1007/s12325-023-02633-8 |
Ejemplares similares
-
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
por: Uchida, Haruhito A., et al.
Publicado: (2022) -
Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study
por: Kario, Kazuomi, et al.
Publicado: (2023) -
Rationale and design of the EMPYREAN study
por: Motoki, Hirohiko, et al.
Publicado: (2020) -
Rationale and Design of the Efficacy and Safety of Esaxerenone in Hypertensive Patients With Left Ventricular Hypertrophy (ESES-LVH) Study ― Protocol for a Multicenter, Open-Label, Exploratory Interventional Study ―
por: Sueta, Daisuke, et al.
Publicado: (2022) -
Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)